Abeona Therapeutics (ABEO) Interest Coverage Ratio (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Interest Coverage Ratio of 16.97 for Q1 2026, down 17.36% year-over-year from 20.54 in Q1 2025, and down 237.5% quarter-over-quarter from 12.34 in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 16.97 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 17.36% year-over-year to 16.97; the TTM figure through Mar 2026 stood at 68.35 (down 33.94% YoY), while the FY2025 annual figure was 1.19, up 92.18% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 16.97, down from 12.34 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 12.34 in Q4 2025, with the low at 121.18 in Q4 2023.
- The 5-year median for Interest Coverage Ratio is 9.89 (2024), against an average of 18.44.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio plunged 1680.29% in 2023, then soared 180.11% in 2025.
- Abeona Therapeutics' Interest Coverage Ratio stood at 72.67 in 2022, then slumped by 66.75% to 121.18 in 2023, then jumped by 87.28% to 15.41 in 2024, then jumped by 180.11% to 12.34 in 2025, then tumbled by 237.5% to 16.97 in 2026.
- Business Quant data shows ABEO's Interest Coverage Ratio at 16.97 in Q1 2026, 12.34 in Q4 2025, and 16.83 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | -19.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.62 |
| Mar 31, 2026 | -27.75 |
| Dec 31, 2025 | -25.92 |
| Sep 30, 2025 | -26.66 |
| Jun 30, 2025 | -23.82 |
| Mar 31, 2025 | -19.77 |
| Dec 31, 2024 | -15.41 |
| Sep 30, 2024 | -13.92 |
| Jun 30, 2024 | -16.66 |
| Mar 31, 2024 | -15.05 |
| Dec 31, 2023 | -121.18 |
| Sep 30, 2023 | -107.94 |
| Jun 30, 2023 | -102.47 |
| Mar 31, 2023 | -119.19 |
| Dec 31, 2022 | -72.67 |
| Sep 30, 2022 | -59.75 |
| Jun 30, 2022 | -40.04 |
| Mar 31, 2022 | -102.44 |
| Dec 31, 2021 | -880.23 |
| Sep 30, 2021 | -21.77 |